메뉴 건너뛰기




Volumn 17, Issue 9, 2010, Pages 624-630

A survey of chronic hepatitis B patient management practices in the European Union

Author keywords

alanine aminotransferase; antiviral therapy; chronic hepatitis B; European patients with CHB; liver disease; serum HBV DNA

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

EID: 77955401739     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01318.x     Document Type: Article
Times cited : (13)

References (18)
  • 1
    • 77955412339 scopus 로고    scopus 로고
    • European Centre for Disease Prevention and Control. Presented December 15, 2008. Sweden. Stockholm
    • European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe 2008. Presented December 15, 2008, Sweden : Stockholm, 2008.
    • (2008) Annual Epidemiological Report on Communicable Diseases in Europe 2008
  • 2
    • 54549127290 scopus 로고    scopus 로고
    • Surveillance and epidemiology of hepatitis B and C in Europe: A review
    • Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe: a review. Euro Surveill 2008 13 : 1 8.
    • (2008) Euro Surveill , vol.13 , pp. 1-8
    • Rantala, M.1    Van De Laar, M.J.2
  • 3
    • 56749161381 scopus 로고    scopus 로고
    • High impact of migration on the prevalence of chronic hepatitis B in the Netherlands
    • Marschall T, Kretzschmar M, Mangen MJ, Schalm S. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol 2008 20 : 1214 1225.
    • (2008) Eur J Gastroenterol Hepatol , vol.20 , pp. 1214-1225
    • Marschall, T.1    Kretzschmar, M.2    Mangen, M.J.3    Schalm, S.4
  • 5
    • 58149296156 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: Management of chronic hepatitis B
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009 50 : 227 242.
    • (2009) J Hepatol , vol.50 , pp. 227-242
  • 6
    • 35548938169 scopus 로고    scopus 로고
    • Long-term outcomes in hepatitis B: The REVEAL-HBV study
    • Chen CJ, Iloeje UH, Yang HI. Long-term outcomes in hepatitis B: the REVEAL-HBV study. Clin Liver Dis 2007 11 : 797 816.
    • (2007) Clin Liver Dis , vol.11 , pp. 797-816
    • Chen, C.J.1    Iloeje, U.H.2    Yang, H.I.3
  • 7
    • 34547488366 scopus 로고    scopus 로고
    • Risk and predictors of mortality associated with chronic hepatitis B infection
    • Iloeje UH, Yang HI, Jen CL et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol 2007 5 : 921 931.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 921-931
    • Iloeje, U.H.1    Yang, H.I.2    Jen, C.L.3
  • 8
    • 19544391413 scopus 로고    scopus 로고
    • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    • Liaw YF, Sung JJ, Chow WC et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004 351 : 1521 1531.
    • (2004) N Engl J Med , vol.351 , pp. 1521-1531
    • Liaw, Y.F.1    Sung, J.J.2    Chow, W.C.3
  • 9
    • 33746558210 scopus 로고    scopus 로고
    • Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases
    • Zarski JP, Marcellin P, Leroy V et al. Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases. J Hepatol 2006 45 : 355 360.
    • (2006) J Hepatol , vol.45 , pp. 355-360
    • Zarski, J.P.1    Marcellin, P.2    Leroy, V.3
  • 10
    • 51049107683 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
    • Liaw Y-F, Leung N, Kao J-H et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008 2 : 263 283.
    • (2008) Hepatol Int , vol.2 , pp. 263-283
    • Liaw, Y.-F.1    Leung, N.2    Kao, J.-H.3
  • 11
    • 33847701354 scopus 로고    scopus 로고
    • Chronic hepatitis B
    • Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 : 507 539.
    • (2007) Hepatology , vol.45 , pp. 507-539
    • Lok, A.S.1    McMahon, B.J.2
  • 12
    • 42949107039 scopus 로고    scopus 로고
    • Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT
    • Kumar M, Sarin SK, Hissar S et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008 134 : 1376 1384.
    • (2008) Gastroenterology , vol.134 , pp. 1376-1384
    • Kumar, M.1    Sarin, S.K.2    Hissar, S.3
  • 13
    • 35748984106 scopus 로고    scopus 로고
    • The clinical significance of persistently normal ALT in chronic hepatitis B infection
    • Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 2007 47 : 760 767.
    • (2007) J Hepatol , vol.47 , pp. 760-767
    • Lai, M.1    Hyatt, B.J.2    Nasser, I.3    Curry, M.4    Afdhal, N.H.5
  • 14
    • 41749120886 scopus 로고    scopus 로고
    • High prevalence of significant histologic disease in patients with chronic hepatitis B (CHB) and normal ALT (abstract no. 993)
    • Nguyen MH, Trinh H, Garcia RT et al. High prevalence of significant histologic disease in patients with chronic hepatitis B (CHB) and normal ALT (abstract no. 993). Hepatology 2007 46 : 680A.
    • (2007) Hepatology , vol.46
    • Nguyen, M.H.1    Trinh, H.2    Garcia, R.T.3
  • 15
    • 56149086622 scopus 로고    scopus 로고
    • Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    • Papatheodoridis GV, Manesis EK, Manolakopoulos S et al. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Hepatology 2008 48 : 1451 1459.
    • (2008) Hepatology , vol.48 , pp. 1451-1459
    • Papatheodoridis, G.V.1    Manesis, E.K.2    Manolakopoulos, S.3
  • 16
    • 48749098663 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B virus infection: Dutch national guidelines
    • Buster EH, van Erpecum KJ, Schalm SW et al. Treatment of chronic hepatitis B virus infection: Dutch national guidelines. Neth J Med 2008 66 : 292 306.
    • (2008) Neth J Med , vol.66 , pp. 292-306
    • Buster, E.H.1    Van Erpecum, K.J.2    Schalm, S.W.3
  • 17
    • 45949110825 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B: Recommendations from an Italian workshop
    • Carosi G, Rizzetto M. Treatment of chronic hepatitis B: recommendations from an Italian workshop. Dig Liver Dis 2008 40 : 603 617.
    • (2008) Dig Liver Dis , vol.40 , pp. 603-617
    • Carosi, G.1    Rizzetto, M.2
  • 18
    • 49849094760 scopus 로고    scopus 로고
    • The German guideline for the management of hepatitis B virus infection: Short version
    • Cornberg M, Protzer U, Dollinger MM et al. The German guideline for the management of hepatitis B virus infection: short version. J Viral Hepat 2008 15 (Suppl. 1 1 21.
    • (2008) J Viral Hepat , vol.15 , Issue.SUPPL. 1 , pp. 1-21
    • Cornberg, M.1    Protzer, U.2    Dollinger, M.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.